Evid Invest

Fair value · Evotec SE (EVO) · updated 2026-10-24 · from 20-F FY2025

Evotec trades at $1.50. We are not reading assumptions out of that price: our price is for one ADS, which represents 0.5 ordinary shares, but this company files its per-share figures per ordinary share — so these methods need a per-share restatement we do not yet publish.

Everything below is unaffected: the filed statements, the filing they came from, and EVO’s growth history are all as reported.

The filing behind these numbers

Evotec SE
Revenue
EUR 788.4M
Diluted EPS
EUR -0.58
Free cash flow
EUR -81.7M
operating cash flow − capital expenditure
Diluted shares
177.6M
weighted average

20-F FY2025 · fiscal year ended 2025-12-31 · filed 2026-04-08 · accession 0001104659-26-040767

Open this filing on sec.gov
EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.